These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7059324)

  • 1. Increased apoprotein B in very low density lipoproteins of patients with peripheral vascular disease.
    Franceschini G; Bondioli A; Mantero M; Sirtori M; Tattoni G; Biasi G; Sirtori CR
    Arteriosclerosis; 1982; 2(1):74-80. PubMed ID: 7059324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic approach to the diagnosis and treatment of atherosclerotic peripheral vascular disease.
    Montanari G; Vaccarino V; Franceschini G; Sirtori M; Bondioli A; Sirtori CR
    Int Angiol; 1987; 6(4):339-49. PubMed ID: 3330115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
    Huff MW; Breckenridge WC; Strong WL; Wolfe BM
    Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compositional and metabolic heterogeneity of alpha 2- and beta-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia.
    Kushwaha RS; Haffner SM; Foster DM; Hazzard WR
    Metabolism; 1985 Nov; 34(11):1029-38. PubMed ID: 4058307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns.
    Franceschini G; Sirtori CR; Bosisio E; Gualandri V; Orsini GB; Mogavero AM; Capurso A
    Atherosclerosis; 1985 Dec; 58(1-3):159-74. PubMed ID: 3937534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of tocopherol on plasma lipids and lipoproteins in man.
    Kesaniemi YA; Grundy SM
    Am J Clin Nutr; 1982 Aug; 36(2):224-8. PubMed ID: 7102581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between the apoprotein C composition of very-low-density lipoproteins and triglyceridemia in subjects with type IV hyperlipoproteinemia.
    Lambert D; Max JP; Mejean L; Pointel JP; Drouin P; Debry G
    J Lab Clin Med; 1981 Jun; 97(6):834-41. PubMed ID: 7229513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.
    Magill P; Rao SN; Miller NE; Nicoll A; Brunzell J; St Hilaire J; Lewis B
    Eur J Clin Invest; 1982 Apr; 12(2):113-20. PubMed ID: 6807682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormality.
    Franceschini G; Sirtori M; Gianfranceschi G; Sirtori CR
    Metabolism; 1981 May; 30(5):502-9. PubMed ID: 6785551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.
    Wakabayashi Y; Okubo M; Shimada H; Sato N; Koide A; Marumo F; Nakamura H
    Metabolism; 1987 Sep; 36(9):815-20. PubMed ID: 3626863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis?
    Goldstein S; Duhamel G; Laudat MH; Berthelier M; Hervy C; Tete MJ; Broyer M
    Nephron; 1984; 38(2):87-92. PubMed ID: 6433214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
    Melnik B; Bros U; Plewig G
    Dermatologica; 1987; 175 Suppl 1():158-68. PubMed ID: 2961629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.